Seven consensus statements developed by 23 international opinion leaders in the acute care of patients with severe traumatic brain injury (sTBI) provide a clear interpretation of clinical trial results that compared intracranial pressure (ICP)-based management to a treatment protocol guided by CT-imaging and examination without ICP monitoring. Results of the BEST TRIP trial led to on-going debate over the value of ICP monitoring in sTBI. These new consensus statement, which will help guide practicing physicians and researchers, are free.
In ‘A Consensus-Based Interpretation of the Benchmark Evidence from South American Trials: Treatment of Intracranial Pressure Trial,’ Randall Chesnut, MD, University of Washington, Seattle, and an international team of researchers present their consensus opinions on the Benchmark Evidence from South American Trials: Treatment of Intracranial Pressure (BEST TRIP). The seven consensus statements that emerged from their discussions help clarify the trial protocols, the different patient outcomes with and without ICP monitoring, the validity of the trial, and the main implications of the trial results.
‘This brief but eloquent consensus report helps revisit the overall implications and interpretations derived from the BEST TRIP trial,’ says John T. Povlishock, PhD, Editor-in-Chief of Journal of Neurotrauma and Professor, Medical College of Virginia Campus of Virginia Commonwealth University, Richmond. ‘As noted by the authors, this consensus document reframes many of the controversial issues generated in this initial trial, calling for a more critical evaluation of the study and its overall interpretation. From my perspective as Editor-in-Chief, I believe the consensus positions detailed therein help place this trial in the appropriate intellectual framework, while highlighting the continued need for more rigorous evaluation of intracranial hypertension, its monitoring, and its implications for traumatically brain-injured patients.’ EurekAlert